November 2024 clinical trial highlights
November 07, 2024
In the November 2024 clinical trial highlights, we'll showcase just a few of the many trials that are open for enrollment and seeking volunteers. To view more available trials for various forms of interstitial lung disease, please visit the 🔍 PFF Clinical Trial Finder.
Seeking relatives of people with familial pulmonary fibrosis
Mechanisms of Familial Pulmonary Fibrosis
- Study ID: NCT03437486
- Intervention: Blood or biological sample collection
- Sponsor: Vanderbilt University Medical Center
- Study Contact: Tisra H Fadely, RN (Tisra.h.fadely@vumc.org)
Seeking participants with idiopathic pulmonary fibrosis and systemic sclerosis-associated interstitial lung disease
MOONSCAPE
- Study ID: NCT05785624
- Trial Phase: Phase 2
- Intervention: Subcutaneous (SC) injection
- Sponsor: Genentech, Inc.
- Study Contact: 888.662.6728, global-roche-genentech-trials@gene.com
Seeking participants with pulmonary hypertension associated with interstitial lung disease
PHocus
- Study ID: NCT06635850
- Trial Phase: Phase 2
- Intervention: Inhaled drug
- Sponsor: Pulmovant, Inc.
- Study Contact: +1.919.462.1310, clinicaltrials@pulmovant.com
Did you know? There are different types of clinical trials!
Clinical
trials are research studies that explore whether a drug, treatment,
device, or medical strategy is safe and effective for humans. These
studies follow strict scientific standards to protect patients and
produce reliable research results.
Clinical trials can take several different forms:
- In interventional studies, participants are assigned by the investigator to a drug, treatment, or other intervention, and their outcomes are measured.
- In observational studies, participants are observed (without being given a drug, treatment, or other intervention) and their outcomes are measured by the investigators. The PFF Community Registry is one example of an observational study in which participants have agreed that their data may be used in this way.
- In expanded access studies, the U.S. Food and Drug Administration (FDA) allows manufacturers to provide new drugs that are still being researched to patients with serious diseases or conditions who cannot participate in a clinical trial.
Want to learn more about clinical trials? Download the clinical trials guide to learn more about clinical trials for pulmonary fibrosis treatment.